Is Metabolic Score for Visceral Fat

Background: Visceral adiposity is an important risk factor for cardiometabolic diseases. Objective: To determine whether the Metabolic Score for Visceral Fat (METS-VF) is more effective than other adiposity indices in predicting visceral fat area (VFA). Methods: In this single-center and cross-secti...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes, metabolic syndrome and obesity metabolic syndrome and obesity, 2023-09, Vol.16, p.2605
Main Authors: Erbakan, Ayse Naciye, Oguz, Aytekin, Akbas, Muhammet Mikdat, Ankarali, Handan, Gunduz, Nesrin, Uzunlulu, Mehmet, Torun, Cundullah, Dogan, Mahmut Bilal, Castur, Lutfullah
Format: Article
Language:English
Subjects:
Adipose tissues
Body mass index
Coronary heart disease
CT imaging
Lipids
Medical research
Medicine, Experimental
Obesity
Risk factors
Type 2 diabetes
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Visceral adiposity is an important risk factor for cardiometabolic diseases. Objective: To determine whether the Metabolic Score for Visceral Fat (METS-VF) is more effective than other adiposity indices in predicting visceral fat area (VFA). Methods: In this single-center and cross-sectional study, we included patients aged 20-50 years, without diabetes and coronary artery disease, who underwent computed tomography (CT) including the third lumbar vertebra. Age, blood pressure, waist circumference (WC), hip circumference, fasting lipids, and glucose were assessed. VFA was measured by cross-sectional examination of CT. The correlation of WC, body mass index (BMI), waist-hip ratio (WHR), lipid accumulation product (LAP), visceral adiposity index (VAI), a body shape index (ABSI), body roundness index (BRI), and METS-VF with VFA was analyzed by correlation analysis. The cut-off values and area under the curve (AUC) for identifying increased VFA (>130 [cm.sup.2]) were determined. Results: We included 185 individuals with mean age 38.2 [+ or -] 8 and female predominance (58.4%). There was a significant positive correlation between all indices and VFA (p6.5 in females and WC cut-off point >88 cm in males (AUC 0.922), >90.5 cm in females (AUC 0.938). Conclusion: METS-VF is strongly associated with visceral adiposity and better to predict increased VFA. However, its superiority over WC, BMI, BRI, and LAP was not significant. The results emphasize that WC is more appealing as screening indicator for visceral adiposity considering its easy use. Clinical Trial Registry Name: Clinicaltrials.gov ( Clinical Trial Registry Url: Clinical Trial Registry Number: NCT05648409. Keywords: obesity, cardiometabolic risk, hypertriglyceridemic waist, body shape, anthropometric measurements
ISSN:1178-7007
1178-7007